These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 14754693)

  • 1. Effect of raloxifene on urinary incontinence: a randomized controlled trial.
    Waetjen LE; Brown JS; Modelska K; Blackwell T; Vittinghoff E; Cummings SR;
    Obstet Gynecol; 2004 Feb; 103(2):261-6. PubMed ID: 14754693
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predictors of hot flushes in postmenopausal women who receive raloxifene therapy.
    Aldrighi JM; Quail DC; Levy-Frebault J; Aguas F; Kosian K; Garrido L; Bosio-Le Goux B; Saráchaga M; Graebe A; Niño AJ; Nickelsen T
    Am J Obstet Gynecol; 2004 Dec; 191(6):1979-88. PubMed ID: 15592280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The long-term effect of raloxifene on the genitourinary tract.
    Sharma S; Albertazzi P; Bottazzi M
    Climacteric; 2007 Jun; 10(3):244-8. PubMed ID: 17487651
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Postmenopausal hormone therapy and risk of developing urinary incontinence.
    Grodstein F; Lifford K; Resnick NM; Curhan GC
    Obstet Gynecol; 2004 Feb; 103(2):254-60. PubMed ID: 14754692
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Continuing outcomes relevant to Evista: breast cancer incidence in postmenopausal osteoporotic women in a randomized trial of raloxifene.
    Martino S; Cauley JA; Barrett-Connor E; Powles TJ; Mershon J; Disch D; Secrest RJ; Cummings SR;
    J Natl Cancer Inst; 2004 Dec; 96(23):1751-61. PubMed ID: 15572757
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and tolerability of solifenacin in elderly subjects with overactive bladder syndrome: a pooled analysis.
    Wagg A; Wyndaele JJ; Sieber P
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):14-24. PubMed ID: 16730617
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of urge-predominant mixed urinary incontinence with tolterodine extended release: a randomized, placebo-controlled trial.
    Khullar V; Hill S; Laval KU; Schiøtz HA; Jonas U; Versi E
    Urology; 2004 Aug; 64(2):269-74; discussion 274-5. PubMed ID: 15302476
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Long-term efficacy of Burch colposuspension: a 14-year follow-up study.
    Kjølhede P
    Acta Obstet Gynecol Scand; 2005 Aug; 84(8):767-72. PubMed ID: 16026403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Lower urinary tract symptoms and pelvic floor muscle exercise adherence after 15 years.
    Bø K; Kvarstein B; Nygaard I
    Obstet Gynecol; 2005 May; 105(5 Pt 1):999-1005. PubMed ID: 15863536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary and anal incontinence in morbidly obese women considering weight loss surgery.
    Richter HE; Burgio KL; Clements RH; Goode PS; Redden DT; Varner RE
    Obstet Gynecol; 2005 Dec; 106(6):1272-7. PubMed ID: 16319252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Predictors of urinary incontinence in a prospective cohort of postmenopausal women.
    Jackson SL; Scholes D; Boyko EJ; Abraham L; Fihn SD
    Obstet Gynecol; 2006 Oct; 108(4):855-62. PubMed ID: 17012446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Menopausal symptoms and treatment-related effects of estrogen and progestin in the Women's Health Initiative.
    Barnabei VM; Cochrane BB; Aragaki AK; Nygaard I; Williams RS; McGovern PG; Young RL; Wells EC; O'Sullivan MJ; Chen B; Schenken R; Johnson SR;
    Obstet Gynecol; 2005 May; 105(5 Pt 1):1063-73. PubMed ID: 15863546
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of raloxifene and calcium plus vitamin D on vaginal atrophy after discontinuation of long-standing postmenopausal hormone therapy in osteoporotic women. A randomized, masked-evaluator, one-year, prospective study.
    Checa MA; Garrido A; Prat M; Conangla M; Rueda C; Carreras R
    Maturitas; 2005 Sep; 52(1):70-7. PubMed ID: 16143228
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Predictors of persistent detrusor overactivity after transvaginal sling procedures.
    Gamble TL; Botros SM; Beaumont JL; Goldberg RP; Miller JJ; Adeyanju O; Sand PK
    Am J Obstet Gynecol; 2008 Dec; 199(6):696.e1-7. PubMed ID: 18845297
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy, safety and tolerability of fesoterodine for overactive bladder syndrome.
    Nitti VW; Dmochowski R; Sand PK; Forst HT; Haag-Molkenteller C; Massow U; Wang J; Brodsky M; Bavendam T
    J Urol; 2007 Dec; 178(6):2488-94. PubMed ID: 17937959
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of botulinum toxin B on refractory detrusor overactivity: a randomized, double-blind, placebo controlled, crossover trial.
    Ghei M; Maraj BH; Miller R; Nathan S; O'Sullivan C; Fowler CJ; Shah PJ; Malone-Lee J
    J Urol; 2005 Nov; 174(5):1873-7; discussion 1877. PubMed ID: 16217327
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The elderly patient with urge incontinence or urge-stress incontinence - efficacy and cardiac safety of propiverine].
    Dorschner W; Stolzenburg JU; Griebenow R; Halaska M; Brünjes R; Frank M; Wieners F
    Aktuelle Urol; 2003 Mar; 34(2):102-8. PubMed ID: 14566693
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Long-term results with tension-free vaginal tape on mixed and stress urinary incontinence.
    Holmgren C; Nilsson S; Lanner L; Hellberg D
    Obstet Gynecol; 2005 Jul; 106(1):38-43. PubMed ID: 15994615
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety assessment of raloxifene over eight years in a clinical trial setting.
    Martino S; Disch D; Dowsett SA; Keech CA; Mershon JL
    Curr Med Res Opin; 2005 Sep; 21(9):1441-52. PubMed ID: 16197663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.